193 related articles for article (PubMed ID: 10030435)
1. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
Kälviäinen R
J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsy Behav; 2006 Jun; 8(4):750-5. PubMed ID: 16647884
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of adjunctive therapy with tiagabine in mentally disabled patients with epilepsy.
Chmielewska B; Stelmasiak Z
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):226-36. PubMed ID: 12898928
[TBL] [Abstract][Full Text] [Related]
5. A review of the antiepileptic drug tiagabine.
Schachter SC
Clin Neuropharmacol; 1999; 22(6):312-7. PubMed ID: 10626090
[TBL] [Abstract][Full Text] [Related]
6. Tiagabine.
Schachter SC
Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
[TBL] [Abstract][Full Text] [Related]
7. Tiagabine: new preparation. Refractory partial epilepsy: another alternative.
Prescrire Int; 1998 Aug; 7(36):99-101. PubMed ID: 10342943
[TBL] [Abstract][Full Text] [Related]
8. [Clinical implications of pharmacology and pharmacokinetics of tiagabine].
Pita-Calandre E
Rev Neurol; 1999 Feb 1-15; 28(3):337-9. PubMed ID: 10714305
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of tiagabine: a prospective open-label study.
Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
[TBL] [Abstract][Full Text] [Related]
10. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
Adkins JC; Noble S
Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
[TBL] [Abstract][Full Text] [Related]
11. Tiagabine for epilepsy.
Med Lett Drugs Ther; 1998 Apr; 40(1024):45-6. PubMed ID: 9580745
[No Abstract] [Full Text] [Related]
12. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.
Halonen T; Nissinen J; Jansen JA; Pitkänen A
Eur J Pharmacol; 1996 Mar; 299(1-3):69-81. PubMed ID: 8901009
[TBL] [Abstract][Full Text] [Related]
13. Tiagabine add-on for drug-resistant partial epilepsy.
Pereira J; Marson AG; Hutton JL
Cochrane Database Syst Rev; 2002; (3):CD001908. PubMed ID: 12137637
[TBL] [Abstract][Full Text] [Related]
14. Introduction to zonisamide.
Baulac M
Epilepsy Res; 2006 Feb; 68 Suppl 2():S3-9. PubMed ID: 16413170
[TBL] [Abstract][Full Text] [Related]
15. [symbol: see text] Tiagabine: add-on treatment for partial seizures.
Drug Ther Bull; 2000 Jun; 38(6):47-8. PubMed ID: 10912300
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
Baulac M; Leppik IE
Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the effectiveness of add-on therapy with tiagabine and evaluation of cognitive functions after application of this therapy in patients with drug-resistant focal epilepsy - an observational study (GABI-EPI)].
Halczuk I; Lipa A; Mitosek-Szewczyk K; Sobolewski P; Stelmasiak Z; Kaczyński K
Wiad Lek; 2015; 68(4 Pt 2):680-9. PubMed ID: 27162312
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K
Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
[TBL] [Abstract][Full Text] [Related]
19. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
[TBL] [Abstract][Full Text] [Related]
20. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine.
Sills GJ
Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
